|
Categories
Pharmaceutical Company
Pharmaceutical Sales
Pharmaceutical
Distributor
Pharmaceutical
Preparation
Pharmaceutical
Jobs
Pharmaceutical
Industry
Pharmaceutical
Drug
Pharmaceutical
Sales Jobs
Pharmaceutical
Product
Pharmaceutical
News
Pharmaceutical
Research
Pharmaceutical
Manufacturer
Pharmaceutical Sales
Rep
Pharmaceutical
Sales Resume
Pharmaceutical
Online
Pharmaceutical
Marketing
Pharmaceutical
Dictionary
Pharmaceutical
Recruiter
Pharmaceutical
Supply
Pharmaceutical
Technology
Pharmaceutical
Advertising
Pharmaceutical
Schools
Companies
Pfizer Pharmaceutical
Wyeth Pharmaceutical
Watson Pharmaceutical
Merck Pharmaceutical
Roche Pharmaceutical
King Pharmaceutical
Teva Pharmaceutical
Aventis
Pharmaceutical
Novartis
Pharmaceutical
Forest
Pharmaceutical
Tap
Pharmaceutical
Shire
Pharmaceutical
Mayne
Pharmaceutical
Millennium
Pharmaceutical
Lilly
Pharmaceutical
Mylan
Pharmaceutical
Kos
Pharmaceutical
Takeda
Pharmaceutical
Endo
Pharmaceutical
Janssen
Pharmaceutical
Barr
Pharmaceutical
Abbott
Pharmaceutical
Reliant
Pharmaceutical
Solvay
Pharmaceutical
Amylin
Pharmaceutical
Vertex
Pharmaceutical
Osi
Pharmaceutical
Bayer
Pharmaceutical
Voyager
Pharmaceutical
Mcneil
Pharmaceutical
Boehringer
Ingelheim
Astra
Zeneca Pharmaceutical
Glaxosmithkline
Pharmaceutical
Novo Nordisk
Pharmaceutical
3m
Pharmaceutical
Eli
Lilly Pharmaceutical
Elan Pharmaceutical
Ivax
Pharmaceutical
Search engines:
Google
Lycos
AltaVista
Yahoo
Mirago
Ask
Teoma
Excite |
|
|
|
King Pharmaceutical
King Pharmaceutical
King, an
S&P 500 Index company, is a vertically integrated branded pharmaceutical
company that develops, manufactures and markets therapies and technologies
primarily in the therapeutic areas of cardiovascular/metabolics, neuroscience,
and hospital/acute care. King has unique strengths in commercialization,
advanced clinical development, manufacturing, and regulatory affairs, which
make the company a proven partner of choice for late stage compounds and novel
branded prescription pharmaceutical products and technologies.
King
Pharmaceuticals has a well recognized and highly prescribed portfolio of core
marketed products (white text in adjacent graphic) in its three therapeutic
areas, plus other products. In addition, King has a robust R&D pipeline
(yellow text in adjacent graphic), including three products in Phase III and
two products in Phase II of clinical development.
More about King
Pharmaceuticals
King Pharmaceuticals® began operations in
January 1994, after purchasing the company’s Bristol facility and assuming
contracts to manufacture prescription pharmaceutical products for such
prominent companies as SmithKline Beecham Corporation, predecessor to
GlaxoSmithKline, and Novartis.
For the next ten years, King
Pharmaceuticals principally focused on the manufacture, acquisition, and
commercialization of previously approved products. Under new leadership, the
company shifted its strategy to position itself to become a leading developer
and acquirer of novel branded pharmaceutical products in later stages of
development, focusing on three main therapeutic areas,
cardiovascular/metabolic, neuroscience, and hospital/acute care.
King
Pharmaceuticals' labor force has grown from an initial 145 to approximately
2700 employees involved in every discipline of a major pharmaceutical company,
including sales and marketing, research and development, regulatory affairs,
quality management, and manufacturing.
King Pharmaceuticals - Sales
& marketing
As the company has grown, so have its marketing
capabilities. Today, King’s dedicated field sales force includes more than
1000 individuals throughout the U.S. and Puerto Rico, a tremendous increase
over the 24 sales professionals that the company employed in
1994.
King Pharmaceuticals - Research and
development
King’s 70-person strong in-house R&D team
includes drug development scientists, regulatory and drug safety staff who
manage the full range of R&D activities for late-stage products: drug
discovery, clinical development, drug safety, regulatory affairs, medical
affairs and project management. Additionally, King has established a highly
cost-effective, readily scalable, R&D model that sets it apart from other
pharmaceutical companies.
King Pharmaceuticals - further
information
www.kingpharm.com
Page last updated:
27/04/06 |
|
|
|
|
